Cargando…

Are there socioeconomic inequalities in polypharmacy among older people? A systematic review and meta-analysis

BACKGROUND: Socioeconomic status (SES) may influence prescribing, concordance and adherence to medication regimens. This review set out to investigate the association between polypharmacy and an individual’s socioeconomic status. METHODS: A systematic review and meta-analyses of observational studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Iqbal, Anum, Richardson, Charlotte, Iqbal, Zain, O’Keefe, Hannah, Hanratty, Barbara, Matthews, Fiona E., Todd, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024437/
https://www.ncbi.nlm.nih.gov/pubmed/36934249
http://dx.doi.org/10.1186/s12877-023-03835-z
_version_ 1784909100783501312
author Iqbal, Anum
Richardson, Charlotte
Iqbal, Zain
O’Keefe, Hannah
Hanratty, Barbara
Matthews, Fiona E.
Todd, Adam
author_facet Iqbal, Anum
Richardson, Charlotte
Iqbal, Zain
O’Keefe, Hannah
Hanratty, Barbara
Matthews, Fiona E.
Todd, Adam
author_sort Iqbal, Anum
collection PubMed
description BACKGROUND: Socioeconomic status (SES) may influence prescribing, concordance and adherence to medication regimens. This review set out to investigate the association between polypharmacy and an individual’s socioeconomic status. METHODS: A systematic review and meta-analyses of observational studies was conducted across four databases. Older people (≥ 55 years) from any healthcare setting and residing location were included. The search was conducted across four databases: Medline (OVID), Web of Science, Embase (OVID) and CINAHL. Observational studies from 1990 that reported polypharmacy according to SES were included. A random-effects model was undertaken comparing those with polypharmacy (≥ 5 medication usage) with no polypharmacy. Unadjusted odds ratios (ORs), 95% confidence intervals (CIs) and standard errors (SE) were calculated for each study. RESULTS: Fifty-four articles from 13,412 hits screened met the inclusion criteria. The measure of SES used were education (50 studies), income (18 studies), wealth (6 studies), occupation (4 studies), employment (7 studies), social class (5 studies), SES categories (2 studies) and deprivation (1 study). Thirteen studies were excluded from the meta-analysis. Lower SES was associated with higher polypharmacy usage: individuals of lower educational backgrounds displayed 21% higher odds to be in receipt of polypharmacy when compared to those of higher education backgrounds. Similar findings were shown for occupation, income, social class, and socioeconomic categories. CONCLUSIONS: There are socioeconomic inequalities in polypharmacy among older people, with people of lower SES significantly having higher odds of polypharmacy. Future work could examine the reasons for these inequalities and explore the interplay between polypharmacy and multimorbidity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-023-03835-z.
format Online
Article
Text
id pubmed-10024437
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100244372023-03-19 Are there socioeconomic inequalities in polypharmacy among older people? A systematic review and meta-analysis Iqbal, Anum Richardson, Charlotte Iqbal, Zain O’Keefe, Hannah Hanratty, Barbara Matthews, Fiona E. Todd, Adam BMC Geriatr Research BACKGROUND: Socioeconomic status (SES) may influence prescribing, concordance and adherence to medication regimens. This review set out to investigate the association between polypharmacy and an individual’s socioeconomic status. METHODS: A systematic review and meta-analyses of observational studies was conducted across four databases. Older people (≥ 55 years) from any healthcare setting and residing location were included. The search was conducted across four databases: Medline (OVID), Web of Science, Embase (OVID) and CINAHL. Observational studies from 1990 that reported polypharmacy according to SES were included. A random-effects model was undertaken comparing those with polypharmacy (≥ 5 medication usage) with no polypharmacy. Unadjusted odds ratios (ORs), 95% confidence intervals (CIs) and standard errors (SE) were calculated for each study. RESULTS: Fifty-four articles from 13,412 hits screened met the inclusion criteria. The measure of SES used were education (50 studies), income (18 studies), wealth (6 studies), occupation (4 studies), employment (7 studies), social class (5 studies), SES categories (2 studies) and deprivation (1 study). Thirteen studies were excluded from the meta-analysis. Lower SES was associated with higher polypharmacy usage: individuals of lower educational backgrounds displayed 21% higher odds to be in receipt of polypharmacy when compared to those of higher education backgrounds. Similar findings were shown for occupation, income, social class, and socioeconomic categories. CONCLUSIONS: There are socioeconomic inequalities in polypharmacy among older people, with people of lower SES significantly having higher odds of polypharmacy. Future work could examine the reasons for these inequalities and explore the interplay between polypharmacy and multimorbidity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-023-03835-z. BioMed Central 2023-03-18 /pmc/articles/PMC10024437/ /pubmed/36934249 http://dx.doi.org/10.1186/s12877-023-03835-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Iqbal, Anum
Richardson, Charlotte
Iqbal, Zain
O’Keefe, Hannah
Hanratty, Barbara
Matthews, Fiona E.
Todd, Adam
Are there socioeconomic inequalities in polypharmacy among older people? A systematic review and meta-analysis
title Are there socioeconomic inequalities in polypharmacy among older people? A systematic review and meta-analysis
title_full Are there socioeconomic inequalities in polypharmacy among older people? A systematic review and meta-analysis
title_fullStr Are there socioeconomic inequalities in polypharmacy among older people? A systematic review and meta-analysis
title_full_unstemmed Are there socioeconomic inequalities in polypharmacy among older people? A systematic review and meta-analysis
title_short Are there socioeconomic inequalities in polypharmacy among older people? A systematic review and meta-analysis
title_sort are there socioeconomic inequalities in polypharmacy among older people? a systematic review and meta-analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024437/
https://www.ncbi.nlm.nih.gov/pubmed/36934249
http://dx.doi.org/10.1186/s12877-023-03835-z
work_keys_str_mv AT iqbalanum aretheresocioeconomicinequalitiesinpolypharmacyamongolderpeopleasystematicreviewandmetaanalysis
AT richardsoncharlotte aretheresocioeconomicinequalitiesinpolypharmacyamongolderpeopleasystematicreviewandmetaanalysis
AT iqbalzain aretheresocioeconomicinequalitiesinpolypharmacyamongolderpeopleasystematicreviewandmetaanalysis
AT okeefehannah aretheresocioeconomicinequalitiesinpolypharmacyamongolderpeopleasystematicreviewandmetaanalysis
AT hanrattybarbara aretheresocioeconomicinequalitiesinpolypharmacyamongolderpeopleasystematicreviewandmetaanalysis
AT matthewsfionae aretheresocioeconomicinequalitiesinpolypharmacyamongolderpeopleasystematicreviewandmetaanalysis
AT toddadam aretheresocioeconomicinequalitiesinpolypharmacyamongolderpeopleasystematicreviewandmetaanalysis